Thyroid Associated Ophthalmopathy

A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Efficacy and Safety of Tocilizumab for TAO

Multi-model Image of Doxycycline in TAO

Multi-model Image of Immunosuppressive Agents in TAO

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy

Effects of Atorvastatin in Graves' Orbitopathy (GO)

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO

Natural History and Risk Factors of TAO

Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial

Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy

Rituximab in the Treatment of Graves' Disease